Goserelin plus tamoxifen versus tamoxifen alone, in pre-menopausal or peri-menopausal patients with hormone receptor-positive early-stage breast cancer: A randomised controlled trial in China. (June 2016) - Yang, H.J.; Yu, X.F.; Zong, X.Y.; Chen, D.B.; Ding, X.W.; Yu, Y.; Zou, D.H.; He, X.M.; Feng, W.L.; Chen, J.; Mo, W.J.; Wang, C.